E74-like Factor 3 (ELF3) Impacts on Matrix Metalloproteinase 13 (MMP13) Transcriptional Control in Articular Chondrocytes under Proinflammatory Stress*
暂无分享,去创建一个
Ko Hashimoto | Yefu Li | P. Oettgen | M. Goldring | K. Marcu | M. Otero | Y. Zhan | Mary B Goldring | Darren A Plumb | L. Tan | Miguel Otero | Kaneyuki Tsuchimochi | Cecilia L Dragomir | Haibing Peng | Eleonora Olivotto | Michael Bevilacqua | Lujian Tan | Zhiyong Yang | Yumei Zhan | Peter Oettgen | Kenneth B Marcu | Hai-bing Peng | K. Tsuchimochi | C. Dragomir | M. Bevilacqua | E. Olivotto | Zhiyong Yang | Yefu Li | K. Hashimoto | D. Plumb
[1] C. Brinckerhoff,et al. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. , 2000, Arthritis and rheumatism.
[2] Jing Wu,et al. Regulation of epithelium-specific Ets-like factors ESE-1 and ESE-3 in airway epithelial cells: potential roles in airway inflammation , 2008, Cell Research.
[3] C. López-Otín,et al. Biochemical Characterization of Human Collagenase-3 (*) , 1996, The Journal of Biological Chemistry.
[4] Francis Berenbaum,et al. Primary culture and phenotyping of murine chondrocytes , 2008, Nature Protocols.
[5] J. Pelletier,et al. Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites. , 2001, The Journal of rheumatology.
[6] T. Libermann,et al. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. , 2003, Arthritis and rheumatism.
[7] M. Lotz,et al. Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. , 1996, The Journal of clinical investigation.
[8] D. Boyd,et al. Regulation of matrix metalloproteinase gene expression , 2007, Journal of cellular physiology.
[9] Judith Sylvester,et al. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. , 2002, Matrix biology : journal of the International Society for Matrix Biology.
[10] K. Vuolteenaho,et al. Inhibitors of Mitogen-Activated Protein Kinases Downregulate COX-2 Expression in Human Chondrocytes , 2005, Mediators of inflammation.
[11] I. Kola,et al. Inactivation of the transcription factor Elf3 in mice results in dysmorphogenesis and altered differentiation of intestinal epithelium. , 2002, Gastroenterology.
[12] R. Borzì,et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. , 1998, Arthritis and rheumatism.
[13] D. Woolley,et al. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. , 2001, Arthritis and rheumatism.
[14] A. Poole,et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. , 2001, The Journal of clinical investigation.
[15] J. Glowacki,et al. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. , 1994, The Journal of clinical investigation.
[16] A. Freemont,et al. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific , 1997, Annals of the rheumatic diseases.
[17] J. Pelletier,et al. A novel negative regulatory element in the human collagenase-3 proximal promoter region. , 2002, Biochemical and biophysical research communications.
[18] Gillian Murphy,et al. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? , 2008, Nature Clinical Practice Rheumatology.
[19] R. Neve,et al. The epithelium‐specific Ets transcription factor ESX is associated with mammary gland development and involution , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] T. Aigner,et al. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. , 2002, Arthritis and rheumatism.
[21] H. Roach,et al. Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. , 2011, European cells & materials.
[22] T. Libermann,et al. GADD45β Enhances Col10a1 Transcription via the MTK1/MKK3/6/p38 Axis and Activation of C/EBPβ-TAD4 in Terminally Differentiating Chondrocytes* , 2010, The Journal of Biological Chemistry.
[23] M. Trojanowska. Ets factors and regulation of the extracellular matrix , 2000, Oncogene.
[24] J. Pelletier,et al. Identification in human osteoarthritic chondrocytes of proteins binding to the novel regulatory site AGRE in the human matrix metalloprotease 13 proximal promoter. , 2006, Arthritis and rheumatism.
[25] J. Pelletier,et al. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. , 1996, The Journal of clinical investigation.
[26] T. Libermann,et al. ESE-1 Is a Novel Transcriptional Mediator of Angiopoietin-1 Expression in the Setting of Inflammation* , 2004, Journal of Biological Chemistry.
[27] L. Joosten,et al. TNF-induced structural joint damage is mediated by IL-1 , 2007, Proceedings of the National Academy of Sciences.
[28] J. Bahn,et al. ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells , 2008, Molecular Cancer Therapeutics.
[29] H. Otu,et al. Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes. , 2008, Arthritis and rheumatism.
[30] J. Tentler,et al. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells , 2004, Oncogene.
[31] A. Sharrocks,et al. The ETS-domain transcription factor family. , 1997, Nature reviews. Molecular cell biology.
[32] Y. Iwamoto,et al. CCAAT/enhancer binding protein beta mediates expression of matrix metalloproteinase 13 in human articular chondrocytes in inflammatory arthritis. , 2009, Arthritis and rheumatism.
[33] A. Rizzino,et al. Different Domains of the Transcription Factor ELF3 Are Required in a Promoter-specific Manner and Multiple Domains Control Its Binding to DNA* , 2007, Journal of Biological Chemistry.
[34] I. Rebay,et al. Post‐translational modifications influence transcription factor activity: A view from the ETS superfamily , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.
[35] M. Jefferson,et al. Protein Kinase C Isoforms ζ and ι Mediate Collagenase Expression and Cartilage Destruction via STAT3- and ERK-dependent c-fos Induction* , 2010, The Journal of Biological Chemistry.
[36] T. Libermann,et al. ESE‐1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes , 2008, Journal of cellular physiology.
[37] L. Joosten,et al. IL-1αβ Blockade Prevents Cartilage and Bone Destruction in Murine Type II Collagen-Induced Arthritis, Whereas TNF-α Blockade Only Ameliorates Joint Inflammation , 1999, The Journal of Immunology.
[38] A. Andalucia. Interferon a increases metalloproteinase-13 gene expression through a polyomavirus enhancer activator 3-dependent pathway in hepatic stellate cells q , 2009 .
[39] J. Tentler,et al. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression. , 2003, DNA and cell biology.
[40] S. Reddy,et al. Interplay between Proximal and Distal Promoter Elements Is Required for Squamous Differentiation Marker Induction in the Bronchial Epithelium , 2003, Journal of Biological Chemistry.
[41] Meenakshi Singh,et al. The ETS Transcription Factor ESE-1 Transforms MCF-12A Human Mammary Epithelial Cells via a Novel Cytoplasmic Mechanism , 2004, Molecular and Cellular Biology.
[42] Y. Pei,et al. Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects. , 2006, Osteoarthritis and cartilage.
[43] T. Libermann,et al. Characterization of ESE-2, a Novel ESE-1-related Ets Transcription Factor That Is Restricted to Glandular Epithelium and Differentiated Keratinocytes* , 1999, The Journal of Biological Chemistry.
[44] J. Norman,et al. Basic Fibroblast Growth Factor Activates the MAPK and NFκB Pathways That Converge on Elk-1 to Control Production of Matrix Metalloproteinase-13 by Human Adult Articular Chondrocytes* , 2007, Journal of Biological Chemistry.
[45] Linda J. Sandell,et al. Egr-1 Mediates Transcriptional Repression of COL2A1Promoter Activity by Interleukin-1β* , 2003, The Journal of Biological Chemistry.
[46] J. Solís-Herruzo,et al. Interferon alpha increases metalloproteinase-13 gene expression through a polyomavirus enhancer activator 3-dependent pathway in hepatic stellate cells. , 2009, Journal of hepatology.
[47] P. Nagarajan,et al. Ets1 Induces Dysplastic Changes When Expressed in Terminally-Differentiating Squamous Epidermal Cells , 2009, PloS one.
[48] B. Olsen,et al. Activation of the Discoidin Domain Receptor 2 Induces Expression of Matrix Metalloproteinase 13 Associated with Osteoarthritis in Mice*♦ , 2005, Journal of Biological Chemistry.
[49] T. Libermann,et al. ESE-3, a Novel Member of an Epithelium-specific Ets Transcription Factor Subfamily, Demonstrates Different Target Gene Specificity from ESE-1* , 2000, The Journal of Biological Chemistry.
[50] A. Fosang,et al. Cytokine-induced increases in ADAMTS-4 messenger RNA expression do not lead to increased aggrecanase activity in ADAMTS-5-deficient mice. , 2010, Arthritis and rheumatism.
[51] S. Grinstein,et al. Interleukin‐1β induction of c‐fos and collagenase expression in articular chondrocytes: Involvement of reactive oxygen species , 1998 .
[52] C. Brinckerhoff,et al. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. , 2001, Nucleic acids research.
[53] Y. Yura,et al. ESE-1 inhibits the invasion of oral squamous cell carcinoma in conjunction with MMP-9 suppression. , 2008, Oral diseases.
[54] Jonghwan Kim,et al. Hypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction , 2010, Nature Medicine.
[55] J. Pelletier,et al. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta. , 2002, The Journal of rheumatology.
[56] C. López-Otín,et al. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13). , 1997, Genomics.
[57] T. Libermann,et al. ESE-1 Is a Novel Transcriptional Mediator of Inflammation That Interacts with NF-κB to Regulate the Inducible Nitric-oxide Synthase Gene* , 2001, The Journal of Biological Chemistry.
[58] T. Libermann,et al. The Ets transcription factor ESE‐1 mediates induction of the COX‐2 gene by LPS in monocytes , 2005, The FEBS journal.
[59] Rakesh Kumar,et al. Phosphorylation-dependent Regulation of Stability and Transforming Potential of ETS Transcriptional Factor ESE-1 by p21-activated Kinase 1* , 2007, Journal of Biological Chemistry.
[60] D. Edwards,et al. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. , 2002, Arthritis and rheumatism.
[61] T. Libermann,et al. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family , 1997, Molecular and cellular biology.
[62] Mahboob Rahman,et al. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[63] B. Graves,et al. An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. , 2002, Genes & development.
[64] A. Sharrocks. The ETS-domain transcription factor family , 2001, Nature Reviews Molecular Cell Biology.
[65] C. Rorabeck,et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. , 1997, The Journal of clinical investigation.
[66] C. Backendorf,et al. Distinct Functional Interactions of Human Skn-1 Isoforms with Ese-1 during Keratinocyte Terminal Differentiation* , 2003, The Journal of Biological Chemistry.
[67] L. Joosten,et al. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. , 1999, Journal of immunology.
[68] Z. Werb,et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. , 2009, Arthritis and rheumatism.
[69] K. Geoghegan,et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. , 1996, The Journal of clinical investigation.
[70] N. Fukui,et al. CCAAT/Enhancer-binding Proteins β and δ Mediate the Repression of Gene Transcription of Cartilage-derived Retinoic Acid-sensitive Protein Induced by Interleukin-1β* , 2002, The Journal of Biological Chemistry.
[71] S. Jimenez,et al. Osteoarthritis cartilage histopathology: grading and staging. , 2006, Osteoarthritis and cartilage.
[72] R. Heller,et al. Cytokine Control of Interstitial Collagenase and Collagenase-3 Gene Expression in Human Chondrocytes* , 1996, The Journal of Biological Chemistry.